ARCHIVES

Prevention Trial Could Stand On Its Own

This article is from The Cancer Letter archive.

Vol. 20 No. 41 | October 28, 1994

Download PDF Visit The Full Archive

Related Articles

In Brief: Columbia’s Marks Reportedly Will Move To MSK; FDA Committee to Consider THC For Group C List

May 23, 1980

Britol-Meyers Holds Taxol Briefings, Outlines Timetable

July 5, 1991

CTI Files Appeal Over FDA’s Decision on Pixantrone

December 3, 2010

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990

Cancer Clinical Trials Approved By NCI Last Month Are Listed

October 25, 2002

Severe Shortages Of Many Cancer Drugs Affecting Practices

November 19, 2010